COULTER LH 755 ANALYZER
Report
- Report Number
- 1061932-2011-00238
- Event Type
- Malfunction
- Date Received
- April 6, 2011
- Date of Event
- February 24, 2011
- Report Date
- March 2, 2011
- Manufacturer
- BECKMAN COULTER, INC.
- Product Code
- LOQ
- PMA / PMN Number
- K011342
- Removal / Correction Number
- N/A
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- MEDICAL TECHNOLOGIST
Narratives
SAMPLE COLLECTION AND STORAGE INFORMATION WERE NOT PROVIDED FOR THIS INVESTIGATION. CONTROLS WERE RUN BEFORE AND AFTER THE EVENT. THE UNIT IS CURRENTLY PERFORMING WITHIN QC SPECIFICATIONS WITH RESPECT TO CONTROLS. RAW DATA ANALYSIS REVEALED THAT THE RAW COUNT RATE FOR RUN 1 IS SIGNIFICANTLY HIGHER THAN RUN 2. THE DIFFERENCE IN THE RAW COUNTS IS DIRECTLY RELATED TO THE DIFFERENCES IN THE WBC RESULTS. MOREOVER, THE RAW COUNT RATE TRENDS DOWN WITH COLLECTION TIME FOR RUN 1 WHILE IT REMAINED FLAT FOR RUN 2. A BCI FIELD SERVICE ENGINEER (FSE) REPLACED THE FOLLOWING COMPONENTS: VL3NO TUBE, SOL21, CHECK VALVE, AND VL10. FSE STATED UP VERIFICATION PASSES. RAN PATIENT SPECIMENS FOR SYSTEM VERIFICATION PURPOSES. ROOT CAUSE IS MOST LIKELY ATTRIBUTED TO THE PARTS THAT WERE REPLACED FOR THE SYSTEM DILUTER DURING THE INSTRUMENT SERVICING PERFORMED SUBSEQUENT TO THIS CF EVENT.
A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) IN REGARDS TO ERRONEOUSLY HIGH WBC RESULT WITH NO INSTRUMENT GENERATED FLAGS WHEN COMPARED TO THE REPEAT RUN ON THE COUTLER LH 755 INSTRUMENT. THE REPEAT RUN WAS CONSISTENT WITH THE LOWER WBC OBTAINED BY MANUAL COUNT WHICH THE LAB CONSIDERS CORRECT. NO ERRONEOUS RESULTS WERE REPORTED OUT OF THE LABORATORY. THERE WAS NO DEATH, INJURY, OR CHANGE TO PATIENT TREATMENT ASSOCIATED WITH THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | COULTER LH 755 ANALYZER | AUTOMATED DIFFERENTIAL CELL COUNTER | LOQ | BECKMAN COULTER, INC. | LH 755 | N/A |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |